PAR 0.00% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Type D Response Submitted and Received by the US FDA, page-19

  1. 567 Posts.
    lightbulb Created with Sketch. 236
    LJSM, a deal has never hinged on 2x2 weekly dosing getting approved, it is something that has recently been introduced by the fanboys to try to explain why a deal has not happened.
    The management told us, they were holding off on accepting any partnership offers until after the 008 readout. Well here we are!!!!
    It is all nonsense and we are being fed nothing but B.S. from the managements mouthpieces.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.000(0.00%)
Mkt cap ! $85.70M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 543 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 544 1
View Market Depth
Last trade - 09.07am 01/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.